Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 385–408 of 494 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fish OIl Clear all

Conditions: Obesity, Insulin Resistance
Interventions: Fat biopsy during scheduled abdominal surgery, Fat Aspiration, Fish Oil Supplement; Procedure · Dietary Supplement
Lead sponsor: Mayo Clinic; Other
Eligibility: 30 Years to 50 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Alzheimer's Disease
Interventions: DHA (Docosahexaenoic Acid), Placebo; Drug
Lead sponsor: Alzheimer's Disease Cooperative Study (ADCS); Other
Eligibility: 50 Years and older
Enrollment: 402 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 51
States / cities: Birmingham, Alabama • Phoenix, Arizona • Sun City, Arizona + 41 more

Conditions: Hypertriglyceridemia
Interventions: DHA-rich fish oil versus Phospholipid-rich fish oil; Dietary Supplement
Lead sponsor: Arctic Nutrition AS; Industry
Eligibility: 18 Years to 59 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Addison, Illinois

Conditions: Treated Hypertension
Interventions: Lipoic Acid plus Omega-3 Fatty Acids, Placebo; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 55 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Portland, Oregon

Conditions: Aging
Interventions: Vitamin D3 (cholecalciferol), fish oil; Dietary Supplement · Drug
Lead sponsor: Augusta University; Other
Eligibility: 50 Years and older
Enrollment: 1,054 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Human Milk, Neonate, Breast Milk
Interventions: Targeted Fortification, The Miris Human Milk Analyzer; Dietary Supplement · Device
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: Up to 6 Months
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Venous Leg Ulcer
Interventions: Omeza® OCM™; Device
Lead sponsor: Omeza, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 7
States / cities: Los Angeles, California • Hollywood, Florida • North Port, Florida + 4 more

Conditions: Parenteral Nutrition Associated Liver Disease
Interventions: Omegaven; Drug
Lead sponsor: St. Luke's Health System, Boise, Idaho; Other
Eligibility: Up to 17 Years
U.S. locations: 1
States / cities: Boise, Idaho

Conditions: Pneumonia
Interventions: Ketogenic feeding, Standard feeding; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 55 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: PTSD - Post Traumatic Stress Disorder, Cognitive Dysfunction, Brain Injury, Depression - Major Depressive Disorder, Suicidal Ideation
Interventions: Magnetic e-Resonance Therapy (MeRT), Ibogaine Hydrochloride with Magnesium Sulfate, 5-methoxy-N,N-dimethyltryptamine, Physiological Supplementation; Device · Drug
Lead sponsor: Axial Therapeutic Research; Industry
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Northridge, California

Conditions: Parenteral Nutrition Associated Liver Disease (PNALD), Essential Fatty Acid Deficiency, Malnutrition, Pediatric ALL
Interventions: Omegaven® (fish oil triglycerides) Injectable Emulsion; Drug
Lead sponsor: Fresenius Kabi; Industry
Eligibility: 1 Day to 17 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 10
States / cities: Fountain Valley, California • Los Angeles, California • Chicago, Illinois + 7 more

Conditions: Atrial Fibrillation
Interventions: Lovaza (Fish Oils); Drug
Lead sponsor: St. Luke's-Roosevelt Hospital Center; Other
Eligibility: 18 Years and older
U.S. locations: 3
States / cities: Ridgewood, New Jersey • New York, New York

Conditions: Gastrointestinal Hemorrhage, Clostridium Difficile Colitis
Interventions: Pantoprazole 40 mg IV daily and tube feed., Placebo and tube feed; Drug · Other
Lead sponsor: Mohamed Saad; Other
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Gestational Weight Gain, Diet, Healthy
Interventions: MedDiet Program, ACOG-based Dietary Program; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older · Female only
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Total Parenteral Nutrition-induced Cholestasis
Interventions: Omegaven IV lipid emulsion; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: Up to 17 Years
U.S. locations: 1
States / cities: Park Ridge, Illinois

Conditions: Lipoprotein Metabolism, PCSK9, Proteomics
Interventions: control fish oil, LCMUFA-rich saury oil; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Signs and Symptoms, Digestive
Interventions: probiotic plus fish oil capsule, Fish oil capsule; Dietary Supplement
Lead sponsor: Nutrition 21, Inc.; Industry
Eligibility: 21 Years to 75 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Pembroke Pines, Florida

Conditions: Non-Small Cell Lung Cancer
Interventions: Taxoprexin, Carboplatin, Paclitaxel; Drug
Lead sponsor: American Regent, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 518 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Precancerous Condition, Prostate Cancer
Interventions: green tea catechin extract, fish oil, placebo; Dietary Supplement · Other
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 21 Years to 120 Years · Male only
Enrollment: 89 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2013
U.S. locations: 3
States / cities: Portland, Oregon

Conditions: Increased Drug Resistance
Interventions: Aspirin, Lovaza, Both Aspirin and Lovaza, Placebo; Drug · Other
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years to 50 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Obesity
Interventions: light olive oil, fish oil capsules, flax seed oil capsules; Dietary Supplement
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Hypertriglyceridemia
Interventions: DHA-O, Fish oil, Placebo; Dietary Supplement
Lead sponsor: dsm-firmenich Switzerland AG; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 93 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Addison, Illinois

Conditions: Type 2 Diabetes Mellitus in Obese
Interventions: NDPR diet, USDA healthy eating diet; Other
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer
Interventions: behavioral dietary intervention, omega-3 fatty acid, laboratory biomarker analysis; Behavioral · Dietary Supplement · Other
Lead sponsor: Jonsson Comprehensive Cancer Center; Other
Eligibility: 50 Years to 80 Years · Male only
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

Understanding the Relationship Between Inflammation and Insulin Resistance in the Adipose Tissue

DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease

Bioavailability of EPA and DHA From Two Dietary Supplements

Pilot Study: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Prevention

Effects of Vitamin D and Omega-3 Supplementation on Telomeres in VITAL

Targeted Breast Milk Fortification for Very Low Birth Weight Infants in the NICU

Omeza Combination Therapy With Standard of Care to Standard of Care Alone for Chronic Venous Leg Ulcers

Omegaven Expanded Access Protocol

Ketogenic Approach to Restore Muscle in Older Patients With Community-Acquired Pneumonia - KARMA-P Trial

Trifecta Research Study

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Pulmonary Vein Isolation Outcomes With Fish Oils

Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients.

Implementation of a Mediterranean Diet Program for Overweight or Obese Pregnant Women in a Low-resource Clinical Setting

Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD

Effect of Fish Oil Enriched In Omega-11 Fatty Acid On Lipoprotein Metabolism In Adults

Clinical Trial Evaluating the Viability of L. Casei + Fish Oil Capsules

Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer

Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer

The Effects of Omega-3 Fatty Acids on Aspirin Resistance

Pilot Study of Dietary Modification of Appetite Set Point in Obesity

Efficacy and Safety Study of DHA-O in Adults With Hypertriglyceridemia

Effect of a Plant Rich Diet on in People With Type 2 Diabetes and Obesity

Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer